Memorial Sloan-Kettering Cancer Center

Right up until his final email to a group of people he liked to keep updated on his medical condition, a note which arrived in April, Bret Perry was a beacon of hope. "I don't plan on being a stranger," wrote Perry, who after eight years suffering...

Edward J. Meyer, 75, an executive who once hawked toothpaste for Bristol-Myers and went on to manage how Sun Refining Co. marketed gasoline and A-Plus mini-marts, died Tuesday, May 14, of complications from cancer. A resident of Bryn Mawr and later...

CHICAGO (Reuters) - Melanoma patients treated with two Bristol-Myers Squibb drugs fared much better than those who received either of the medications individually, a new advance for treatments that harness the body's immune system to fight cancer....

NEW YORK (Reuters Health) - A group representing U.S. pediatricians said this week that its members should pay special attention to the healthcare needs of immigrant children and support health insurance for all - regardless of legal status. "It doesn'...

The greatest dangers to liberty lurk in the insidious encroachment by men of zeal, well meaning but without understanding. — Louis D. Brandeis Just a few words and little thought separate yet another stronghold of the American economy from ruin....

Most of us are collectors, whether we display our obsessions in the workplace or hide them in their original boxes at home. We devote hours to researching and buying wine and designer bags, comic books and antique buttons, action figures and shoes. Neil...

Jackson Laboratory researchers say a specific molecule can be used to kill certain cancer cells. For a study in the Journal of Experimental Medicine, researchers at the Bar Habor, Maine, facility of Jackson Laboratory introduced a molecule known as DIDS...

Four of five children facing certain death from leukemia are recovering after treatment that strengthened their immune systems, with no signs of cancer and no need of medicine. Their success is advancing a new medical strategy that bolsters the body's...

It would be fair to say that Patient 5 owes his life to medical research. Also known as David Aponte, he was the headlining success story from a recent clinical trial at Memorial Sloan-Kettering Cancer Center. The trial tested a new approach — in...

A therapy that supercharges the body's immune cells and sends them back in to fight a deadly form of leukemia has shown promise in adult patients who were out of options, according to a new report published Wednesday. Adults who have relapsed after...

NEW YORK (Reuters Health) - People with certain cancers enrolled in clinical trials survive longer, not necessarily from the treatment itself but potentially because those enrolled are better off to begin with, according to new research. "The survival...

Many people have heard of Facebook founder Mark Zuckerberg or Google co-founder Sergey Brin. But few know about Bert Vogelstein, a Johns Hopkins scientist who helped map the cancer genome and created gene and stool tests to detect colon cancer. A new,...